Skip to main content
Harbin Pharmaceutical Group Co.,Ltd. logo

Harbin Pharmaceutical Group Co.,Ltd. — Investor Relations & Filings

Ticker · 600664 ISIN · CNE0000009T3 LEI · 300300G0L086UJ23MI26 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,827 across all filing types
Latest filing 2017-06-23 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 600664

About Harbin Pharmaceutical Group Co.,Ltd.

https://www.hayao.com/

Harbin Pharmaceutical Group Co., Ltd. specializes in the research, development, manufacture, and distribution of a diverse range of pharmaceutical and healthcare products. The company's portfolio includes antibiotics, over-the-counter (OTC) medicines, health supplements, traditional Chinese medicines, and animal health products. It operates through several specialized subsidiaries and maintains a significant presence in the production of penicillins and cephalosporins. A key strategic focus involves the health and nutrition sector, bolstered by the acquisition of global nutrition brand GNC. The company leverages large-scale manufacturing capabilities and an extensive distribution network to serve both domestic and international markets. Its operations emphasize technological innovation and quality control across its integrated supply chain, from raw material production to finished dosage forms.

Recent filings

Filing Released Lang Actions
关于董事会及监事会延期换届的提示性公告
Board/Management Information Classification · 95% confidence The document is a short announcement (610 characters) regarding the postponement of the board of directors and supervisory board re-election. It contains no financial data or detailed report content but is an official notice about management board changes and election timing. This fits the category of Board/Management Information (MANG) as it announces changes or delays in board composition and management terms.
2017-06-23 Chinese
关于收到中信资本控股有限公司说明函的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (712 characters) from Harbin Pharmaceutical Group Co., Ltd. regarding receipt of an explanatory letter from CITIC Capital Holdings Limited. It clarifies control and ownership matters related to a previous announcement about an acquisition. There is no financial data, no detailed report, no meeting materials, no voting results, no executive changes, no legal proceedings, and no financial statements. The document is an official regulatory announcement clarifying ownership/control issues, fitting best under Regulatory Filings (RNS).
2017-06-07 Chinese
关于完成工商变更登记手续的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement from 哈药集团股份有限公司 regarding the completion of industrial and commercial registration changes, specifically the change in registered capital and company address. It mentions approvals from various shareholder meetings and board meetings, and references the revised company articles of association available on the stock exchange website. The document is short (568 characters) and serves as an official notice of these changes rather than a detailed report or financial statement. This fits the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2017-06-06 Chinese
关于控股股东股权结构变动的提示性公告
Major Shareholding Notification Classification · 95% confidence The document is a formal announcement regarding changes in the equity structure of the controlling shareholder of the company Harbin Pharmaceutical Group Co., Ltd. It details the transaction between CITIC Capital Platform Investment Limited and Warburg Pincus entities, the resulting shareholding percentages, and confirms that the actual control of the company remains unchanged. The document includes legal disclaimers, detailed descriptions of the transaction, and the impact on control, but does not contain financial statements, earnings data, or management discussion. It is a notification about a change in shareholding structure, specifically related to the controlling shareholder's equity. This fits the category of Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels. The document length is under 5,000 characters and is a standalone announcement, not a report or presentation. Therefore, the correct classification is MRQ with high confidence.
2017-06-05 Chinese
七届二十次监事会决议公告
Regulatory Filings Classification · 95% confidence The document is a Supervisory Board resolution announcement regarding the approval and review of the company's 2017 first quarter report. It contains the Supervisory Board's opinion on the compliance and accuracy of the quarterly report but does not include the actual financial statements or detailed financial data itself. The document is short (667 characters) and serves as an official announcement of the Supervisory Board's resolution and opinion on the quarterly report rather than the report itself. Therefore, it is best classified as a Regulatory Filing (RNS) because it is a formal announcement related to regulatory compliance and internal review, not the full interim/quarterly report.
2017-04-16 Chinese
七届二十四次董事会决议公告
Regulatory Filings Classification · 95% confidence The document is a board resolution announcement from Harbin Pharmaceutical Group Co., Ltd. regarding the approval of the 2017 first quarter report. It states that the board meeting was held and the quarterly report was approved unanimously. The document is short (443 characters) and refers readers to the full quarterly report published on the Shanghai Stock Exchange website. It does not contain the actual financial statements or substantive financial data itself, but rather announces the board's approval and points to the full report elsewhere. According to the 'Menu vs Meal' rule, this is an announcement about a report, not the report itself. Therefore, the document should be classified as a Regulatory Filing (RNS), which is the fallback category for such announcements that do not contain the full report content.
2017-04-16 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.